Get started
Author

Katrin Pansy

Observed names: K. Pansy, Pansy, Katrin
ORCID: 0000-0001-6972-4937
Observed ORCID: 0000-0001-6972-4937
OpenAlex ID: A5077511326
Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions
2021 · Katrin Pansy, Barbara Uhl, et al. · International Journal of Molecular Sciences · 112
PDF
Targeting the Microenvironment for Treating Multiple Myeloma
2022 · Peter Neumeister, Eduard Schulz, et al. · International Journal of Molecular Sciences · 45
PDF
Non-coding Natural Antisense Transcripts: Analysis and Application
2021 · Julian C. Krappinger, Lilli Bonstingl, et al. · Journal of Biotechnology · 37
PDF
NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes
2017 · Alexander J.A. Deutsch, Beate Rinner, et al. · Cancer Research · 35
PDF
(Dis)similarities between the Decidual and Tumor Microenvironment
2022 · Jelena Krstic, Alexander Deutsch, et al. · Biomedicines · 32
PDF
The CXCR4–CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro
2019 · Katrin Pansy, Julia Feichtinger, et al. · International Journal of Molecular Sciences · 25
PDF
Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter’s Trans-Formed DLBCL and Germinal Center B-Cells
2022 · Barbara Uhl, Katharina T. Prochazka, et al. · International Journal of Molecular Sciences · 12
PDF
Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas
2022 · Barbara Uhl, Katharina T Prochazka, et al. · World Journal of Gastrointestinal Oncology · 12
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survival
2018 · Karoline Fechter, Julia Feichtinger, et al. · Scientific Reports · 7
PDF
Deregulated CXCR4-CXCL12 Signaling Impacts on the Pathogenesis of DLBCL
2019 · Katrin Pansy, Julia Feichtinger, et al. · Blood · 4
The Flavonoid Brusatol Induces Apoptosis in Aggressive Lymphoma Cells and Exhibits Synergistic Effect with Venetoclax
2022 · Marta M. Szmyra, Sandra Haingartner, et al. · Blood · 2
Chemokine Receptor Profiles as Predictors of Survival and Early Progression in Follicular Lymphoma
2025 · Antonella Zupo, Katrin Pansy, et al. · eJHaem
PDF
Exploring the Anti-Tumor Effects of Brusatol in Aggressive B-Cell Lymphomas
2025 · Marta Malwina Szmyra-Połomka, Sandra Haingartner, et al. · bioRxiv (Cold Spring Harbor Laboratory)
Data from NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes
2023 · Alexander J.A. Deutsch, Beate Rinner, et al.
Supplementary Materials and Methods, Supplementary Tables 1 through 5 and Supplementary Figures 1 through 3 from NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes
2023 · Alexander J.A. Deutsch, Beate Rinner, et al.
Supplementary Materials and Methods, Supplementary Tables 1 through 5 and Supplementary Figures 1 through 3 from NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes
2023 · Alexander J.A. Deutsch, Beate Rinner, et al.
Data from NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes
2023 · Alexander J.A. Deutsch, Beate Rinner, et al.
Loss of Nr4a1 Causes an Elevated Expression of Co-Inhibitory Receptor:Ligand Axes and Results in a Diminished T Cell-Mediated Lymphoma Cell Killing in Aggressive Lymphoma
2022 · Katrin Pansy, Karoline Fechter, et al. · Blood
S226: Loss of Nr4a1 Is Associated With Higher Expression of Immune Checkpoint Components and Reduced T Cell-mediated Lymphoma Cell Killing in Aggressive Lymphoma
2022 · K. Pansy, K. Fechter, et al. · HemaSphere
Pb2157: Treatment With Diphenyleneiodonium Chloride Exhibits Cell Growth Inhibitory Effects on Aggressive Lymphoma Cells
2022 · S. Haingartner, S. Jantscher, et al. · HemaSphere
Pb2168: Brusatol Induces Apoptosis in Aggressive Lymphoma Cells in Vitro and Synergizes With Venetoclax
2022 · M. Szmyra, S. Jantscher, et al. · HemaSphere
Works count: 22
Citation count: 323
H-index: 8
I10-index: 8
Year
Topic
Type